Jun 14, 2010 | Laboratory News, Laboratory Pathology
Healthscope bids also fuel speculation of a big clinical pathology transaction Last week in Australia, investment insiders shared rumors that Quest Diagnostics Incorporated (NYSE: DGX) was interested in acquiring Sonic Healthcare Ltd. (ASX: SHL). However, press stories discounted the possibility of a deal between these two billion-dollar clinical pathology laboratory behemoths. Neither company has issued a public statement addressing this issue. In assessing the possibility of Quest...
